# Microbial Transglutaminase Increases Uptake and Translocation of Gliadin Peptides in the Human Intestinal Epithelium

**Authors:** Sebastian Stricker, Jan De Laffolie, Klaus‐Peter Zimmer, Silvia Rudloff

PMC · DOI: 10.1002/mnfr.70197 · 2025-08-11

## TL;DR

This study shows that microbial transglutaminase increases the absorption of harmful gliadin peptides in the human intestine, potentially contributing to celiac disease.

## Contribution

The study demonstrates that microbial transglutaminase significantly enhances gliadin peptide uptake in intestinal cells and human tissue.

## Key findings

- Microbial transglutaminase has a higher affinity for gliadin peptides than human transglutaminase 2.
- Microbial transglutaminase increases the uptake of gliadin peptides P56-88 and P31-49 by nearly 10 times in Caco-2 cells.
- Microbial transglutaminase colocalizes with gliadin peptides in human duodenal mucosa.

## Abstract

Transglutaminase 2 (TG2) plays an essential role in the pathogenesis of celiac disease (CD) by modifying gliadin peptides. Additionally, microbial transglutaminase (mTG) was implicated in CD pathogenesis since it modifies gliadin peptides in the same way. mTG is used as a technical aid in the production of food items and might also be released by the intestinal microbiota. We aimed to characterize the interaction of mTG with different gliadin peptides and its effect on the epithelial and mucosal transport.We compared mTG‐ and TG2‐mediated crosslinking of gliadin peptides using indirect enzyme‐linked immunosorbent assay (ELISA) and immunoblot. Epithelial uptake of gliadin peptides P56‐88 and P31‐49 by Caco‐2 cells and human duodenal biopsies was quantified by fluorometry and immunofluorescence microscopy. mTG had a much higher affinity towards different gliadin peptides than TG2. mTG significantly increased the uptake of gliadin peptide P56‐88 and P31‐49 by Caco‐2 cells by nearly 10 times. Finally, mTG increased the uptake and colocalized with gliadin peptide P56‐88 in the human duodenal mucosa. DmTG‐mediated enzymatic modification of gliadin peptides is evident and influences the epithelial uptake of potentially detrimental gliadin peptides. The uncritical use of mTG in food production might therefore pose a potential threat for consumers.

The bacterial enzyme microbial transglutaminase (mTG) is widely used in the food industry as a technological aid to improve textural properties of a multitude of food products. mTG mimics the enzymatic function of human transglutaminase 2 (TG2) and may play a role in the pathogenesis of celiac disease. Here, we demonstrate that mTG has a high affinity to different gliadin peptides and significantly increases their uptake by intestinal epithelial cells and the human duodenal mucosa.

## Linked entities

- **Diseases:** celiac disease (MONDO:0005130)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TGM2 (transglutaminase 2) [NCBI Gene 7052] {aka G(h), TG(C), TGC, hTG2, tTG}
- **Diseases:** CD (MESH:D002446)
- **Chemicals:** Gliadin Peptides (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12581733/full.md

---
Source: https://tomesphere.com/paper/PMC12581733